ArticleIntensive care medicine experimental2025
Establishment of a neonatal rat model of sequential hyperoxic hypoxia to recapitulate clinical progression of bronchopulmonary dysplasia-associated pulmonary hypertension.
Article in Intensive care medicine experimental, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundBronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH) seriously threatens the lives of preterm infants. The absence of animal models that can simulate its progression from early hyperoxic lung injury to late hypoxic vascular remodeling has hindered related research.
objectiveTo establish a neonatal rat BPD-PH model by simulating exposure to sequential hyperoxic hypoxia experienced by human preterm infants.
methodsNewborn SD rats were randomized into two control groups (C1 exposed to 21% O₂ for 2 weeks; C2 exposed to 21% O₂ for 3 weeks), and three exposure groups (H1 exposed to 75% O₂ for 2 weeks; H2 exposed to 75% O₂ for 2 weeks and then to 10% O₂ for a week; H3 exposed to 75% O₂ for 2 weeks and then to normoxia for a week). Cardiopulmonary parameters were evaluated by echocardiography, right ventricular systolic pressure measurement, histology, and α-SMA immunofluorescence.
resultsH1 and H2 groups exhibited distinct phenotypes, with those in the H2 group showing more severe phenotypes. The H2 group exhibited a 142% increase in RVSP relative to those in the C2 group. The right-heart index (RI) was 0.43 ± 0.01 in the H2 group, 0.36 ± 0.02 in the H3 group, and 0.22 ± 0.03 in the C2 group. Pulmonary vascular remodeling was significantly increased in the H2 group compared to the control and H3 groups. The H2 group uniquely replicated the disease process, with alveolar simplification preceding hypoxia-induced vascular thickening.
conclusionThe sequential hyperoxic hypoxia model dynamically mimicked the clinical progression of BPD-PH, which may provide a powerful platform for stage-specific mechanism research and development of novel therapeutic strategies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.